The ExoVasc® Personalised External Aortic Root Support is a revolutionary new device. It is designed to manage aortic dilation in people with Marfan syndrome and related genetic conditions. The ExoVasc® is placed around the ascending aorta where it provides support to the patient’s own aorta and aortic valve and is designed to prevent enlargement and rupture. A further application is in the Ross Operation where the ExoVasc® is used to manage dilation of the transplanted pulmonary valve when replacing the first part of the aorta. This innovation developed by Exstent Limited sets a new standard in the surgical management of the dilated aorta. More than 800 patients have now received their ExoVasc® support and its effectiveness is proven by a total of over 2,000 patient-years’ experience gained during the past 19 years.
View Top Employees from EXSTENT LIMITED| Website | http://www.exstent.com/ |
| Revenue | $5 million |
| Employees | 9 (6 on RocketReach) |
| Founded | 2002 |
| Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Manufacturing |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular EXSTENT LIMITED employee's phone or email?
EXSTENT LIMITED Questions
The EXSTENT LIMITED annual revenue was $5 million in 2024.
Tal Golesworthy is the Technical Director of EXSTENT LIMITED.
6 people are employed at EXSTENT LIMITED.
The NAICS codes for EXSTENT LIMITED are [339, 33].
The SIC codes for EXSTENT LIMITED are [384, 38].
Top EXSTENT LIMITED Employees
-
2
-
42
-
31
-
Related Companies
